• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟雾病患者搭桥手术前后循环血管内皮生长因子拮抗细胞因子和血管稳定因子的表达

Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease.

作者信息

He Jin, Wang Rong, Zhang Dong, Zhang Yan, Zhang Qian, Zhao Jizong

机构信息

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.

出版信息

Exp Ther Med. 2014 Jul;8(1):302-308. doi: 10.3892/etm.2014.1713. Epub 2014 May 14.

DOI:10.3892/etm.2014.1713
PMID:24944638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4061224/
Abstract

The aim of the present study was to investigate the levels of vascular endothelial growth factor (VEGF)-antagonizing cytokines and VEGF-influenced vascular stabilizing cytokines in patients with moyamoya disease (MMD) and the association with postoperative collateral vessel formation. The study population included 53 MMD patients that had undergone indirect bypass surgery and 50 healthy controls. Serum levels of VEGF, thrombospondin-1 (TSP-1), TSP-2, soluble VEGF receptor-1 (sVEGFR-1), sVEGFR-2, endostatin, angiopoietin-1 (Ang-1) and Ang-2 were measured at the baseline (preoperative) and at day seven following surgery. Postoperative collateralization assessment was conducted upon the six-month follow-up cerebral angiography. Cytokine levels were compared between patients with good or poor collateral formation. Compared with the healthy controls, MMD patients exhibited lower baseline levels of sVEGFR-1 (P<0.0001) and sVEGFR-2 (P<0.0001), but higher VEGF expression (P<0.0001). Ang-1 and Ang-2 levels did not exhibit any difference between the two groups. On day seven following surgery, MMD patients exhibited an almost unchanged sVEGFR-1 and sVEGFR-2 expression level, but upregulated expression of VEGF (P<0.0001), Ang-1 (P<0.0001) and TSP-2 (P<0.0001). The six-month follow-up angiographies revealed that 21 patients (45.65%) that had undergone the same surgical procedure achieved good collateralization. Patients with good collateral formation appeared to have lower sVEGFR-1 and sVEGFR-2 levels prior to (P=0.029 and P=0.045, respectively) and at day seven (P=0.044 and P=0.047, respectively) following bypass surgery when compared with the patients with worse collateralization. Therefore, sVEGFR-1 and sVEGFR-2 may play a role in the pathogenesis of MMD. Lower levels of sVEGFR-1 and sVEGFR-2 indicated better postoperative collateralization in the six months following indirect bypass surgery. However, Ang-1 and Ang-2 may not be specifically involved in the course of MMD.

摘要

本研究的目的是调查烟雾病(MMD)患者中血管内皮生长因子(VEGF)拮抗细胞因子和VEGF影响的血管稳定细胞因子的水平,以及与术后侧支血管形成的相关性。研究人群包括53例接受间接搭桥手术的MMD患者和50例健康对照者。在基线(术前)和术后第7天测量血清VEGF、血小板反应蛋白-1(TSP-1)、TSP-2、可溶性VEGF受体-1(sVEGFR-1)、sVEGFR-2、内皮抑素、血管生成素-1(Ang-1)和Ang-2的水平。在术后6个月的脑血管造影时进行术后侧支循环评估。比较侧支形成良好或不良患者的细胞因子水平。与健康对照者相比,MMD患者的sVEGFR-1(P<0.0001)和sVEGFR-2(P<0.0001)基线水平较低,但VEGF表达较高(P<0.0001)。两组之间的Ang-1和Ang-2水平没有差异。术后第7天,MMD患者的sVEGFR-1和sVEGFR-2表达水平几乎没有变化,但VEGF(P<0.0001)、Ang-1(P<0.0001)和TSP-2(P<0.0001)的表达上调。术后6个月的血管造影显示,21例(45.65%)接受相同手术的患者侧支循环良好。与侧支循环较差的患者相比,侧支形成良好的患者在搭桥手术前(分别为P=0.029和P=0.045)和术后第7天(分别为P=0.044和P=0.047)的sVEGFR-1和sVEGFR-2水平似乎较低。因此,sVEGFR-1和sVEGFR-2可能在MMD的发病机制中起作用。较低的sVEGFR-1和sVEGFR-2水平表明间接搭桥手术后6个月的术后侧支循环较好。然而,Ang-1和Ang-2可能未特别参与MMD的病程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe28/4061224/6f49a90e0bf4/ETM-08-01-0302-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe28/4061224/6f49a90e0bf4/ETM-08-01-0302-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe28/4061224/6f49a90e0bf4/ETM-08-01-0302-g00.jpg

相似文献

1
Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease.烟雾病患者搭桥手术前后循环血管内皮生长因子拮抗细胞因子和血管稳定因子的表达
Exp Ther Med. 2014 Jul;8(1):302-308. doi: 10.3892/etm.2014.1713. Epub 2014 May 14.
2
Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization.评估血浆可溶性 Tie-2 水平以区分烟雾病与动脉粥样硬化性脑血管病并预测术后新生血管形成。
J Neurosurg. 2023 Jun 16;139(6):1705-1714. doi: 10.3171/2023.4.JNS23479. Print 2023 Dec 1.
3
Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.血清血管生成素-2和可溶性血管内皮生长因子受体-2水平可预测卵巢肿瘤的恶性程度及上皮性卵巢癌的不良预后。
BMC Cancer. 2014 Sep 23;14:696. doi: 10.1186/1471-2407-14-696.
4
Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.血清可溶性血管内皮生长因子受体-1水平升高与稳定型冠状动脉疾病患者较差的冠状动脉侧支循环形成相关。
Circ J. 2014;78(5):1191-6. doi: 10.1253/circj.cj-13-1143. Epub 2014 Feb 28.
5
Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer.晚期乳腺癌患者基线血管内皮生长因子/可溶性血管内皮生长因子受体-2(VEGF/sVEGFR-2)和血管内皮生长因子/血小板反应蛋白-1(VEGF/TSP-1)比值与使用环磷酰胺和塞来昔布的节拍化疗反应之间的关联。
Indian J Cancer. 2013 Apr-Jun;50(2):115-21. doi: 10.4103/0019-509X.117031.
6
Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions.渗出性胸腔积液中可溶性血管内皮生长因子受体1水平升高。
J Med Invest. 2007 Feb;54(1-2):146-53. doi: 10.2152/jmi.54.146.
7
Differential Expression of Vascular Endothelial Growth Factor-A Isoforms Between Intracranial Atherosclerosis and Moyamoya Disease.颅内动脉粥样硬化与烟雾病之间血管内皮生长因子-A亚型的差异表达
J Stroke Cerebrovasc Dis. 2019 Feb;28(2):360-368. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.004. Epub 2018 Nov 2.
8
Caveolin-1 Promoted Collateral Vessel Formation in Patients With Moyamoya Disease.小窝蛋白-1促进烟雾病患者侧支血管形成。
Front Neurol. 2022 Apr 26;13:796339. doi: 10.3389/fneur.2022.796339. eCollection 2022.
9
Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.可溶性血管内皮生长因子受体-1在增生性糖尿病视网膜病变玻璃体中的作用。
Ophthalmology. 2008 Nov;115(11):1916-22. doi: 10.1016/j.ophtha.2008.06.025. Epub 2008 Aug 21.
10
The usefulness of determining the serum concentrations of vascular endothelial growth factor (VEGF) and its soluble receptor type 2 (sVEGF-2) in the differential diagnosis of adrenal incidentalomas.测定血清血管内皮生长因子(VEGF)及其可溶性受体 2(sVEGF-2)浓度在肾上腺意外瘤鉴别诊断中的作用。
Endokrynol Pol. 2012;63(1):22-8.

引用本文的文献

1
Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions.烟雾病的进展:发病机制、诊断及治疗干预
MedComm (2020). 2025 Jan 14;6(2):e70054. doi: 10.1002/mco2.70054. eCollection 2025 Feb.
2
Multi-parameter MRI-Based Machine Learning Model to Evaluate the Efficacy of STA-MCA Bypass Surgery for Moyamoya Disease: A Pilot Study.基于多参数磁共振成像的机器学习模型评估烟雾病颞浅动脉-大脑中动脉搭桥手术的疗效:一项初步研究
J Imaging Inform Med. 2025 Feb;38(1):134-147. doi: 10.1007/s10278-024-01130-w. Epub 2024 Jul 17.
3
Molecular Biomarkers Affecting Moyamoya Disease.

本文引用的文献

1
The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization.VEGF 和 KDR 多态性在烟雾病及其侧支血管重建中的作用。
PLoS One. 2012;7(10):e47158. doi: 10.1371/journal.pone.0047158. Epub 2012 Oct 12.
2
Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease.保守治疗与手术治疗对出血性烟雾病的长期预后影响。
J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):258-65. doi: 10.1136/jnnp-2012-302236. Epub 2012 Sep 25.
3
Bypass surgery for moyamoya disease: concept and essence of sugical techniques.
影响烟雾病的分子生物标志物。
Adv Tech Stand Neurosurg. 2024;49:1-18. doi: 10.1007/978-3-031-42398-7_1.
4
Factors Influencing Collateral Circulation Formation After Indirect Revascularization for Moyamoya Disease: a Narrative Review.影响烟雾病间接血运重建后侧支循环形成的因素:一项叙述性综述。
Transl Stroke Res. 2024 Dec;15(6):1005-1014. doi: 10.1007/s12975-023-01185-x. Epub 2023 Aug 17.
5
The Genetic Basis of Moyamoya Disease.Moyamoya 病的遗传学基础。
Transl Stroke Res. 2022 Feb;13(1):25-45. doi: 10.1007/s12975-021-00940-2. Epub 2021 Sep 16.
6
Pathological Circulating Factors in Moyamoya Disease.烟雾病的病理循环因子。
Int J Mol Sci. 2021 Feb 8;22(4):1696. doi: 10.3390/ijms22041696.
7
The Pathophysiology of Moyamoya Disease: An Update.烟雾病的病理生理学:更新。
J Stroke. 2016 Jan;18(1):12-20. doi: 10.5853/jos.2015.01760. Epub 2016 Jan 29.
烟雾病的搭桥手术:手术技术的概念与精髓
Neurol Med Chir (Tokyo). 2012;52(5):287-94. doi: 10.2176/nmc.52.287.
4
Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.血栓素-1 和 -2 调节血管生成的分子基础。
Cold Spring Harb Perspect Med. 2012 May;2(5):a006627. doi: 10.1101/cshperspect.a006627.
5
Insights on the revascularization mechanism for treatment of Moyamoya disease based on the histopathologic concept of angiogenesis and arteriogenesis.基于血管生成和动脉生成的组织病理学概念对烟雾病治疗中血管重建机制的见解。
World Neurosurg. 2011 Feb;75(2):204-5. doi: 10.1016/j.wneu.2010.10.004.
6
Oculoectodermal syndrome with coarctation of the aorta and moyamoya disease: expanding the phenotype to include vascular anomalies.伴有主动脉缩窄和烟雾病的眼外胚层综合征:扩展表型以纳入血管异常
Am J Med Genet A. 2011 Mar;155A(3):577-81. doi: 10.1002/ajmg.a.33104. Epub 2011 Feb 18.
7
Myocyte vascular endothelial growth factor is required for exercise-induced skeletal muscle angiogenesis.肌细胞血管内皮生长因子是运动诱导骨骼肌血管生成所必需的。
Am J Physiol Regul Integr Comp Physiol. 2010 Oct;299(4):R1059-67. doi: 10.1152/ajpregu.00347.2010. Epub 2010 Aug 4.
8
Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment.可溶性血管内皮生长因子受体-1 和 -2 通过募集壁细胞促进血管成熟。
FASEB J. 2010 Oct;24(10):3782-95. doi: 10.1096/fj.09-149070. Epub 2010 May 19.
9
Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease.烟雾病患者的血浆基质金属蛋白酶、细胞因子和血管生成因子。
J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):673-8. doi: 10.1136/jnnp.2009.191817. Epub 2009 Dec 3.
10
Moyamoya disease: collateralization is everything.烟雾病:侧支循环至关重要。
Cerebrovasc Dis. 2009;28(3):258. doi: 10.1159/000228255. Epub 2009 Jul 14.